Holstein Jens Sells 5,000 Veracyte Shares Amid Merger Buzz, Signals Routine Portfolio Rebalancing【News Flash】
Veracyte insider Holstein Jens sells 5,000 shares at $40.95, a routine portfolio move amid the company’s Convergent Genomics merger and potential bladder cancer diagnostics expansion.
3 minutes to read